Schiff, E, Peleg, E, Goldenberg, M, Rosenthal, T, Ruppin, E, Tamarkin, M, Barkai, G, Ben-Baruch, G, Yahal, I, Blankstein, J, et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 1989;321:351–6.Google Scholar

Benigni, A, Gregorini, G, Frusca, T, Chiabrando, C, Ballerini, S, Valcamonico, A, Orisio, S, Piccinelli, A, Pinciroli, V, Fanelli, R, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989;321:357–62.Google Scholar

Quenby, S, Mountfield, S, Cartwright, JE, Whitley, GS, Vince, G. Effects of low-molecular-weight and unfractionated heparin on trophoblast function. Obstet Gynecol 2004;104:354–61.Google Scholar

Han, CS, Mulla, MJ, Brosens, JJ, Chamley, LW, Paidas, MJ, Lockwood, CJ, Abrahams, VM. Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. Obstet Gynecol 2011;118:1021–8.CrossRefGoogle ScholarPubMed

Henderson, JT, Whitlock, EP, O’Connor, E, Senger, CA, Thompson, JH, Rowland, MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014;160:695–703.Google Scholar

Bujold, E, Roberge, S, Lacasse, Y, Bureau, M, Audibert, F, Marcoux, S, Forest, JC, Giguere, Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402–14.CrossRefGoogle ScholarPubMed

Meher, S, Alfirevic, Z. Aspirin for pre-eclampsia: Beware of subgroup meta-analysis. Ultrasound Obstet Gynecol 2013;41:479–85.Google Scholar

Duley, L, Henderson-Smart, DJ, Meher, S, King, JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007, Issue 2. Art. No.: CD004659.Google Scholar

Henderson, JT, Whitlock, EP, O’Conner, E, Senger, CA, Thompson, JH, Rowland, MG. Low-Dose Aspirin for the Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 112. AHRQ Publication No. 14-05207-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2014.Google Scholar

Rolnik, DL, Wright, D, Poon, LC, O’Gorman, N, Syngelaki, A, de Paco Matallana, C, Akolekar, R, Cicero, S, Janga, D, Singh, M, Molina, FS, Persico, N, Jani, JC, Plasencia, W, Papaioannou, G, Tenenbaum-Gavish, K, Meiri, H, Gizurarson, S, Maclagan, K, Nicolaides, KH. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017;377:613–622.Google Scholar

Askie, LM, Duley, L, Henderson-Smart, DJ, Stewart, LA, Group, PC. Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 2007;369:1791–8.CrossRefGoogle ScholarPubMed

Roberge, S, Nicolaides, KH, Demers, S, Villa, P, Bujold, E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: A meta-analysis. Ultrasound Obstet Gynecol 2013;41:491–9.CrossRefGoogle ScholarPubMed

Ayala, DE, Ucieda, R, Hermida, RC. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy. Chronobiol Int 2013;30:260–79.Google Scholar

Wojtowicz, A, Undas, A, Huras, H, Musial, J, Rytlewski, K, Reron, A, Wilczak, M, Jach, R. Aspirin resistance may be associated with adverse pregnancy outcomes. Neuro Endocrinol Lett 2011;32:334–9.Google Scholar

Wallenburg, HC, Rotmans, N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987;157:1230–5.CrossRefGoogle ScholarPubMed

CLASP: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994;343:619–29.Google Scholar

McParland, P, Pearce, JM, Chamberlain, GV. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet 1990;335:1552–5.Google Scholar

Viinikka, L, Hartikainen-Sorri, AL, Lumme, R, Hiilesmaa, V, Ylikorkala, O. Low dose aspirin in hypertensive pregnant women: Effect on pregnancy outcome and prostacyclin-thromboxane balance in mother and newborn. BJOG 1993;100:809–15.Google Scholar

Caspi, E, Raziel, A, Sherman, D, Arieli, S, Bukovski, I, Weinraub, Z. Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: A preliminary report. Am J Reprod Immunol 1994;31:19–24.Google Scholar

Hermida, RC, Ayala, DE, Iglesias, M, Mojon, A, Silva, I, Ucieda, R, Fernandez, JR. Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 1997;30:589–95.Google Scholar

Caritis, S, Sibai, B, Hauth, J, Lindheimer, MD, Klebanoff, M, Thom, E, Van Dorsten, P, Landon, M, Paul, R, Miodovnik, M, Meis, P, Thurnau, G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;338:701–5.CrossRefGoogle ScholarPubMed

Vainio, M, Kujansuu, E, Iso-Mustajarvi, M, Maenpaa, J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002;109:161–7.Google Scholar

Yu, CK, Papageorghiou, AT, Parra, M, Palma, Dias, R, Nicolaides, KH, Fetal Medicine Foundation Second Trimester Screening G. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks’ gestation. Ultrasound Obstet Gynecol 2003;22:233–9.Google Scholar

Villa, PM, Kajantie, E, Raikkonen, K, Pesonen, AK, Hamalainen, E, Vainio, M, Taipale, P, Laivuori, H, Group, PS. Aspirin in the prevention of pre-eclampsia in high-risk women: A randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG 2013;120:64–74.Google Scholar

Kingdom, JC, Walker, M, Proctor, LK, Keating, S, Shah, PS, McLeod, A, Keunen, J, Windrim, RC, Dodd, JM. Unfractionated heparin for second trimester placental insufficiency: A pilot randomized trial. J Thromb Haemost 2011;9:1483–92.Google Scholar

Kupferminc, M, Rimon, E, Many, A, Maslovitz, S, Lessing, JB, Gamzu, R. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia. Blood Coagul Fibrinolysis 2011;22:123–6.Google Scholar

Duffett, L, Rodger, M. LMWH to prevent placenta-mediated pregnancy complications: An update. Br J Haematol 2014.Google Scholar

Greer, IA, Brenner, B, Gris, JC. Antithrombotic treatment for pregnancy complications: Which path for the journey to precision medicine? Br J Haematol 2014;165:585–99.Google Scholar

Dodd, JM, McLeod, A, Windrim, RC, Kingdom, J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Sys Rev 2013, Issue 7. Art. No.: CD006780.Google Scholar

Rodger, MA, Carrier, M, Le Gal, G, Martinelli, I, Perna, A, Rey, E, De Vries, JI, Gris, JC, Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study G. Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications. Blood 2014;123:822–8.Google Scholar

Rodger, MA, Hague, WM, Kingdom, J, Kahn, SR, Karovitch, A, Sermer, M, Clement, AM, Coat, S, Chan, WS, Said, J, Rey, E, Robinson, S, Khurana, R, Demers, C, Kovacs, MJ, Solymoss, S, Hinshaw, K, Dwyer, J, Smith, G, McDonald, S, Newstead-Angel, J, McLeod, A, Khandelwal, M, Silver, RM, Le Gal, G, Greer, IA, Keely, E, Rosene-Montella, K, Walker, M, Wells, PS, Investigators, T. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet 2014;384:1673–83.CrossRefGoogle Scholar

Mello, G, Parretti, E, Fatini, C, Riviello, C, Gensini, F, Marchionni, M, Scarselli, GF, Gensini, GF, Abbate, R. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women. Hypertension 2005;45:86–91.Google Scholar

Rey, E, Garneau, P, David, M, Gauthier, R, Leduc, L, Michon, N, Morin, F, Demers, C, Kahn, SR, Magee, LA, Rodger, M. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: A pilot randomized controlled trial. J Thromb Haemost 2009;7:58–64.Google Scholar

Gris, JC, Chauleur, C, Molinari, N, Mares, P, Fabbro-Peray, P, Quere, I, Lefrant, JY, Haddad, B, Dauzat, M. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial. Thromb Haemost 2011;106:1053–61.Google Scholar

De Vries, JI, Van Pampus, MG, Hague, WM, Bezemer, PD, Joosten, JH, Investigators, F. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: The FRUIT-RCT. J Thromb Haemost 2012;10:64–72.CrossRefGoogle ScholarPubMed

Martinelli, I, Ruggenenti, P, Cetin, I, Pardi, G, Perna, A, Vergani, P, Acaia, B, Facchinetti, F, La Sala, GB, Bozzo, M, Rampello, S, Marozio, L, Diadei, O, Gherardi, G, Carminati, S, Remuzzi, G, Mannucci, PM, Group, HS. Heparin in pregnant women with previous placenta-mediated pregnancy complications: A prospective, randomized, multicenter, controlled clinical trial. Blood 2012;119:3269–75.Google Scholar

Greer, IA, Nelson-Piercy, C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: A systematic review of safety and efficacy. Blood 2005;106:401–7.CrossRefGoogle ScholarPubMed

Casele, H, Haney, EI, James, A, Rosene-Montella, K, Carson, M. Bone density changes in women who receive thromboprophylaxis in pregnancy. Am J Obstet Gynecol 2006;195:1109–13.Google Scholar